These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 8986942

  • 1. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A, Bissolati M, Cividini A, Nicosia A, Esumi M, Hayashi N, Mizuno K, Slobbe R, Oudshoorn P, Silini E, Asti M, Mondelli MU.
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [Abstract] [Full Text] [Related]

  • 2. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P, López JA, Elola C, Domingo CJ, Echevarria JM.
    Vox Sang; 1996 Jan; 70(4):213-6. PubMed ID: 9123926
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N, Sikuler E, Tovbin D, Neville L, Nussbaum O, Mostoslavsky M, Orgel M, Yaari A, Manor S, Dagan S, Hilzenrat N, Shemer-Avni Y.
    J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
    [Abstract] [Full Text] [Related]

  • 4. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L, Soumillion A, Peerlinck K, Verslype C, Schelstraete R, Gyselinck F, Emonds MP, Hess G, Vermylen J, Desmyter J, Yap SH.
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [Abstract] [Full Text] [Related]

  • 5. Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays.
    Xiang J, Wünschmann S, George SL, Klinzman D, Schmidt WN, LaBrecque DR, Stapleton JT.
    J Med Virol; 2002 Dec; 68(4):537-43. PubMed ID: 12376962
    [Abstract] [Full Text] [Related]

  • 6. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection.
    Yuki N, Hayashi N, Kasahara A, Hagiwara H, Mita E, Ohkawa K, Katayama K, Fusamoto H, Kamada T.
    Hepatology; 1996 May; 23(5):947-52. PubMed ID: 8621173
    [Abstract] [Full Text] [Related]

  • 7. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.
    Fabrizi F, Lunghi G, Guarnori I, Raffaele L, Di Filippo S, Erba G, Pagano A, Locatelli F.
    Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533
    [Abstract] [Full Text] [Related]

  • 8. Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2): is it a marker for immunity?
    Hassoba HM, Terrault NA, el-Gohary AM, Scheffel C, Jou C, Brackett J, Hunt J, Lou SC, Wright TL.
    J Med Virol; 1997 Dec; 53(4):354-60. PubMed ID: 9407383
    [Abstract] [Full Text] [Related]

  • 9. [Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction].
    Benouda A, Boujdiya Z, Ahid S, Abouqal R, Adnaoui M.
    Pathol Biol (Paris); 2009 Jul; 57(5):368-72. PubMed ID: 18842351
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.
    Hepatogastroenterology; 1997 Jul; 44(14):417-25. PubMed ID: 9164512
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P, Medici MC, Casula F, Arcangeletti MC, De Conto F, Pinardi F, Calderaro A, Chezzi C, Dettori G.
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [Abstract] [Full Text] [Related]

  • 12. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
    Brunetto MR, Suzuki T, Aizaky H, Flichman D, Colombatto P, Abate ML, Oliveri F, Matsuura Y, Bonino F, Miyamura T.
    Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
    [Abstract] [Full Text] [Related]

  • 13. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
    Canavese C, Hollò Z, Ciccone G, Ghisetti V, Barbui A, Fop F, Martina G, Forgnone F, Novo P, Thea A, Grill A, Marchiaro G.
    J Nephrol; 2000 Dec; 13(5):352-9. PubMed ID: 11063139
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Dec; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of GBV-C/HGV-RNA, virus genotypes, and anti-E2 antibodies in autoimmune hepatitis.
    Tribl B, Schöniger-Hekele M, Petermann D, Bakos S, Penner E, Müller C.
    Am J Gastroenterol; 1999 Nov; 94(11):3336-40. PubMed ID: 10566740
    [Abstract] [Full Text] [Related]

  • 16. [The prevalence of hepatitis G virus in patients with hepatitis B and C virus infections].
    Kaya S, Cicioğlu Aridoğan B, Demirci M.
    Mikrobiyol Bul; 2004 Oct; 38(4):421-7. PubMed ID: 15700668
    [Abstract] [Full Text] [Related]

  • 17. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
    Aiyama T, Yoshioka K, Okumura A, Takayanagi M, Iwata K, Ishikawa T, Kakumu S.
    Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
    [Abstract] [Full Text] [Related]

  • 18. [Second generation hepatitis-C virus test and polymerase chain reaction in anti-C 100 negative patients with chronic non-A, non-B hepatitis].
    Zala G, Havelka J, Wicki AN, Joller-Jemelka HI, Meier B, Schmid M, Bühler H.
    Schweiz Med Wochenschr; 1992 Mar 14; 122(11):363-8. PubMed ID: 1313601
    [Abstract] [Full Text] [Related]

  • 19. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M, Penning M, van Putten M, Lukashov V, van den Hoek A, McMorrow M, Goudsmit J.
    Hepatology; 1999 Apr 14; 29(4):1288-98. PubMed ID: 10094977
    [Abstract] [Full Text] [Related]

  • 20. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
    Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, Kaiser R, Sauerbruch T, Spengler U.
    Hepatology; 1996 Oct 14; 24(4):790-5. PubMed ID: 8855177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.